Eli Lilly Launches Attacks Of Tirzepatide Generics
Eli Lilly and Co. fired off a round of lawsuits in Delaware federal court seeking to block generic versions of its weight loss and diabetes medications, targeting Sandoz, MSN Laboratories and...To view the full article, register now.
Already a subscriber? Click here to view full article